g/l, between 0*2 and 0-5 was 3*07 g/l, and in those with CD4+ T cell counts below 0-2X109/1 the mean IgA concentration was 4 .58 g/l.
Treatment patterns have altered between 1989 and 1991, with increased use of zidovudine in patients without AIDS and a marked increase in primary prophylaxis against pneumocystis pneumonia. This has been associated with a decline in the incidence of pneumocystis as an indicator disease in new AIDS cases from 56% in 1989 to 20% in 1991.
These observations indicate that persistent generalised lymphadenopathy does not worsen the outlook, but shingles does. Rising IgA concentrations are markers for disease progression. Modern (3) (4) (5) (6) (7) (8) (9) , chest x ray score 20-2 (6 5), forced vital capacity (FVC) % predicted 21-0 (8-2), forced expiratory volume in one second (FEVy %) 28-7 (9 4). At six months' follow up the figures were: clinical score 21-9 (-1-7), chest x ray score 17-9 (4 6), FVC 9'0 (0 9), FEVy % 18-4 (4-9). During the follow up period readmission to hospital was more than 10 
